International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands

Pharmacological Reviews

Volumn 55, Issue 1, 2003, Pages 21-26

  Hauger, Richard L ^a   Grigoriadis, Dimitri E ^b   Dallman, Mary F ^c   Plotsky, Paul M ^d   Vale, Wylie W ^e   Dautzenberg, Frank M ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^f c/o Axovan Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM; COMPLEMENTARY DNA; CORTICOTROPIN RELEASING FACTOR 2ALPHA RECEPTOR; CORTICOTROPIN RELEASING FACTOR 2BETA RECEPTOR; CORTICOTROPIN RELEASING FACTOR 3 RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; GROWTH HORMONE RELEASING FACTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; ISOPROTEIN; LIGAND; MESSENGER RNA; NEUROPEPTIDE; PARATHYROID HORMONE; RECEPTOR SUBTYPE; RELEASING FACTOR; SECRETIN; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN 1; UROCORTIN 2; UROCORTIN III; VASOACTIVE INTESTINAL POLYPEPTIDE;

AMIDATION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; BINDING ASSAY; CARBOXY TERMINAL SEQUENCE; GENETIC CODE; HUMAN; LIGAND BINDING; MOLECULAR CLONING; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; INTERNATIONAL AGENCIES; LIGANDS; MOLECULAR SEQUENCE DATA; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEQUENCE ALIGNMENT; TERMINOLOGY;

EID: 0037370129     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.55.1.3     Document Type: Review

References (59)

1. Arai M, Assil IQ, and Abou-Samra AB (2001) Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis. Endocrinology 142:446-454.
2. Arborelius L, Owens MJ, Plotsky PM, and Nemeroff CB (1999) The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160:1-12.
3. Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, and Sawchenko PE (1999) Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 415:285-312.
4. Brauns O, Brauns S, Zimmermann B, Jahn O, and Spiess J (2002) Differential responsiveness of CRF receptor subtypes to N-terminal truncation of peptidic ligands. Peptides 23:881-888.
5. Cepoi D, Sutton S, Arias C, Sawchenko P, and Vale WW (1999) Ovine genomic urocortin: cloning, pharmacological characterization and distribution of central mRNA. Mol Brain Res 68:109-118.
6. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, and De Souza EB (1996) Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 17:166-172.
7. Chang CP, Pearse RV II, O'Connel S, and Rosenfeld MG (1993) Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11:1187-1195.
8. Chen R, Lewis KA, Perrin MH, and Vale WW (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90:8967-8971.
9. Dautzenberg FM, Dietrich K, Palchaudhuri MR, and Spiess J (1997) Identification of two corticotropin-releasing factor receptors with high ligand selectivity from Xenopus laevis: unusual pharmacology of the type 1 receptor. J Neurochem 69:1640-1649.
10. Dautzenberg FM and Hauger RL (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23:71-77.
11. 2α receptors and the role of position 185 for receptor-ligand selectivity. Neuropharmacology 39:1368-1376.
12. Dautzenberg FM, Kilpatrick GJ, Hauger RL, and Moreau J-L (2001a) Molecular biology of the CRH receptors - in the mood. Peptides 22:753-760.
13. Dautzenberg FM, Py-Lang G, Higelin J, Fischer C, Wright MB, and Huber G (2001b) Different binding modes of amphibian and human CRF type 1 and type 2 receptors: evidence for evolutionary differences. J Pharmacol Exp Ther 296:113-120.
14. De Souza EB, Perrin MH, Insel TR, Rivier J, Vale WW, and Kuhar MJ (1984) Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification. Science (Wash DC) 224:1449-1451.
15. Donaldson C, Sutton S, Perrin MH, Corrigan AZ, Lewis KA, Rivier J, Vaughan JM, and Vale WW (1996) Cloning and characterization of human urocortin. Endocrinology 137:2167-2170.
16. Dunn AJ and Berridge CW (1990) Physiological and behavioral responses of corticotropin releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 15:71-100.
17. Grammatopoulos DK, Dai Y, Randeva HS, Levine MA, Karteris E, Easton AJ, and Hillhouse EW (1999) A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol Endocrinol 13:2189-2202.
18. Hauger RL and Dautzenberg FM (1999) Regulation of the stress response by corticotropin-releasing factor receptors, in Neuroendocrinology in Physiology and Medicine (Conn PM, Freedman ME, eds), pp 261-286, Humana Press, Inc., Totowa, NJ.
19. Heinrichs SC and De Souza EB (1999) Corticotropin-releasing factor antagonists, binding-protein and receptors: implications for central nervous system disorders. Baillere's Best Pract Res Clin Rheumatol 13:541-554.
20. Humphrey PPA and Barnard EA (1998) International Union of Pharmacology. XIX. The IUPHAR receptor code: a proposal for an alphanumeric classification system. Pharmacol Rev 50:271-277.
21. Hsu SY and Hsueh AJW (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7:605-611.
22. Kageyama K, Bradbury MJ, Zhao L, Blount AL, and Vale WW (1999) Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 140:5651-5658.
23. Kishimoto T, Pearse RV II, Lin CR, and Rosenfeld MG (1995) A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92:1108-1112.
24. 2? receptor. Mol Endocrinol 12:1077-1085.
25. Lederis K, Letter A, McMaster D, and Moore G (1982) Complete amino acid sequence of urotensin-I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus. Science (Wash DC) 218:162-164.
26. Lewis K, Li C, Perrin MH, Bount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, and Vale WW (2001) Proc Natl Acad Sci USA 98:7570-7575.
27. Li C, Vaughan J, Sawchenko PE, and Vale WW (2002) Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 22:991-1001.
28. Liaw CW Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, and De Souza EB (1996) Cloning and characterization of the human releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137:72-77.
29. Lovenberg TW, Chalmers DT, Liu C, and De Souza EB (1995a) CRF2α and CRF2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136:4139-4142.
30. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, and Oltersdorf T (1995b) Cloning and characterization of a functionally distinct corticotropin releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840.
31. Miyata I, Shiota C, Ikeda Y, Oshida Y, Chaki S, Okuyama S, and Inagami T (1999) Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala. Biochem Biophys Res Commun 256:692-696.
32. Montecucchi PC and Henschen A (1981) Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of Phyllomedusa sauvagei. Int J Peptide Protein Res 18:113-120.
33. Myers EA, Trinh JV, and Myers TR (1998) Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant. Mol Cell Endocrinol 144:21-35.
34. Nappi RE and Rivest S (1995) Stress-induced genetic expression of a selective corticotropin-releasing factor-receptor subtype within the rat ovaries: an effect dependent on the ovulatory cycle. Biol Reproduct 53:1417-1428.
35. Okawara Y, Morley SD, Burzio LO, Zwiers H, Lederis K, and Richter D (1988) Cloning and sequence analysis of cDNA for corticotropin-releasing factor precursor from the teleost fish Catostomus commersoni. Proc Natl Acad Sci USA 85:8439-8443.
36. Palchaudhuri MR, Hauger RL, Wille S, Fuchs E, and Dautzenberg FM (1999) Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri. J Neuroendocrinol 11:419-428.
37. Palchaudhuri MR, Wille S, Mevenkamp G, Spiess J, Fuchs E, and Dautzenberg FM (1998) Corticotropin-releasing factor receptor type 1 from Tupaia belangeri: cloning, functional expression and tissue distribution. Eur J Biochem 258:78-84.
38. Perrin M, Donaldson C, Chen R, Blunt A, Berggren T, Bilezikjian L, Sawchenko P and Vale W (1995) Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92:2969-2973.
39. Perrin MH, Donaldson CJ, Chen R, Lewis KA, and Vale WW (1993) Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133:3058-3061.
40. Perrin MH, Sutton SW, Cervini LA, Rivier JE, and Vale WW (1999) Comparison of an agonist, urocortin and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J Pharmacol Exp Ther 288:729-734.
41. Pohl S, Darlison MG, Clarke WC, Lederis K, and Richter D (2001) Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish. Eur J Pharmacol 430:193-202.
42. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, and Vale W (1994) Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 91:8777-8781.
43. Reul JM and Holsboer F (2002) Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2:23-33.
44. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JS, Gulyas J, Rivier J, Vale WW, and Sawchenko PE (2001) Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843-2848.
45. Rivier J, Rivier C, and Vale W (1984) Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science (Wash DC) 224:889-891.
46. Ross PC, Kostas CM, and Ramabhadran TV (1994) A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology. Biochem Biophys Res Commun 205:1836-1842.
47. Sanchez MM, Young LJ, Plotsky PM, and Insel TR (1999) Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 408:365-377.
48. Smagin GN, Heinrichs SC, and Dunn AJ (2001) The role of CRH in behavioral responses to stress. Peptides 22:713-724.
49. Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB, and Stenzel-Poore MP (1995) Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 9:637-645.
50. Stenzel-Poore MP, Heldwein KA, Stenzel P, Lee S, and Vale WW (1992) Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians. Mol Endocrinol 6:1716-1724.
51. Swanson LW, Sawchenko PE, Rivier J, and Vale WW (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36:165-186.
52. 2 receptor for corticotropin-releasing factor. Biochim Biophys Acta 1352:129-132.
53. Vale W, Spiess J, Rivier C, and Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science (Wash DC) 213:1394-1397.
54. Vale W, Vaughan J, and Perrin M (1997) Corticotropin-releasing factor (CRF) family of ligands and their receptors. The Endocrinoligist 7:S3-S9.
55. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE and Vale W (1995) Urocortin, a mamalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature (Lond) 378:287-292.
56. Vita N, Laurent P, Lefort S, Chalon P, Lelias JM, Kaghad M, Le Fur G, Caput D, and Ferrara P (1993) Primary structure and functional expression of mouse and human brain corticotropin releasing factor receptors. FEBS Lett 335:1-5.
57. Wynn PC, Hauger RL, Holmes MC, Millan MA, Catt KJ, and Aguilera G (1984) Brain and pituitary receptors for corticotropin releasing factor: Localization and differential regulation after adrenalectomy. Peptides 5:1077-1084.
58. Yu J, Xie LY, and Abou-Samra AB (1996) Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I. Endocrinology 137:192-197.
59. Zhao L, Donaldson CJ, Smith GW, and Vale WW (1998) The structure of the mouse and human urocortin genes. Genomics 50:23-33.